The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday.“Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “But the hope offered by these tools will not materialize unless they are made available to all people in all countries.
I urge governments and companies to live up to their commitments and to use all solutions at their disposal to ramp up production so that these tools become truly